Non-Smad pathways in TGF-β signaling

Derynck R, Miyazono K . TGF-beta and the TGF-beta family. In: Derynck R, Miyazono K, eds. The TGF-beta Family. NewYork: Cold Spring Harbor Laboratory Press, 2008:29–43.

Massagué J, Blain SW, Lo RS . TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295–309.

Derynck R, Akhurst RJ . Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007; 9:1000–1004.

Massagué J . TGFbeta in cancer. Cell 2008; 134:215–230.

Derynck R, Zhang Y . Intracellular signalling: the mad way to do it. Curr Biol 1996; 6:1226–1229.

Massagué J, Seoane J, Wotton D . Smad transcription factors. Genes Dev 2005; 19:2783–2810.

Feng XH, Derynck R . Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659–693.

Schmierer B, Hill CS . TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8:970–982.

Derynck R, Zhang YE . Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425:577–584.

Moustakas A, Heldin CH . Non-Smad TGF-beta signals. J Cell Sci 2005; 118:3573–3584.

Mulder KM, Morris SL . Activation of p21ras by transforming growth factor beta in epithelial cells. J Biol Chem 1992; 267:5029–5031.

Yan Z, Winawer S, Friedman E . Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. J Biol Chem 1994; 269:13231–13237.

Hartsough MT, Mulder KM . Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 1995; 270:7117–7124.

Frey RS, Mulder KM . TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett 1997; 117:41–50.

Mucsi I, Skorecki KL, Goldberg HJ . Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 1996; 271:16567–16572.

Simeone DM, Zhang L, Graziano K, et al. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. Am J Physiol Cell Physiol 2001; 281:C311–C319.

Olsson N, Piek E, Sundstrom M, ten Dijke P, Nilsson G . Transforming growth factor-beta-mediated mast cell migration depends on mitogen-activated protein kinase activity. Cell Signal 2001; 13:483–490.

Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell 2000; 103:211–225.

McKay MM, Morrison DK . Integrating signals from RTKs to ERK/MAPK. Oncogene 2007; 26:3113–3121.

Ravichandran KS . Signaling via Shc family adapter proteins. Oncogene 2001; 20:6322–6330.

Lawler S, Feng XH, Chen RH, et al. The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 1997; 272:14850–14859.

Galliher AJ, Schiemann WP . Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007; 67:3752–3758.

Lee MK, Pardoux C, Hall MC, et al. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 2007; 26:3957–3967.

Thiery JP . Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15:740–746.

Lee JM, Dedhar S, Kalluri R, Thompson EW . The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172:973–981.

Zavadil J, Bitzer M, Liang D, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 2001; 98:6686–6691.

Davies M, Robinson M, Smith E, et al. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005; 95:918–931.

Galliher-Beckley AJ, Schiemann WP . Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. Carcinogenesis 2008; 29:244–251.

Northey JJ, Chmielecki J, Ngan E, et al. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol 2008; 28:3162–3176.

Kretzschmar M, Doody J, Massagué J . Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997; 389:618–622.

Kretzschmar M, Doody J, Timokhina I, Massagué J . A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev 1999; 13:804–816.

Funaba M, Zimmerman CM, Mathews LS . Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002; 277:41361–41368.

Matsuura I, Wang G, He D, Liu F . Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry 2005; 44:12546–12553.

Zhang Y, Feng XH, Derynck R . Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998; 394:909–913.

Hall MC, Young DA, Waters JG, et al. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem 2003; 278:10304–10313.

Weston CR, Davis RJ . The JNK signal transduction pathway. Curr Opin Cell Biol 2007; 19:142–149.

Frey RS, Mulder KM . Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 1997; 57:628–633.

Engel ME, McDonnell MA, Law BK, Moses HL . Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 1999; 274:37413–37420.

Hocevar BA, Brown TL, Howe PH . TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999; 18:1345–1356.

Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 1999; 274:27161–27167.

Sano Y, Harada J, Tashiro S, et al. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J Biol Chem 1999; 274:8949–8957.

Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL . Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 2001; 276:46707–46713.

Yu L, Hebert MC, Zhang YE . TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 2002; 21:3749–3759.

Itoh S, Thorikay M, Kowanetz M, et al. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 2003; 278:3751–3761.

Yamaguchi K, Shirakabe K, Shibuya H, et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270:2008–2011.

Shibuya H, Iwata H, Masuyama N, et al. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 1998; 17:1019–1028.

Shim JH, Xiao C, Paschal AE, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19:2668–2681.

Jadrich JL, O'Connor MB, Coucouvanis E . The TGF beta activated kinase TAK1 regulates vascular development in vivo. Development 2006; 133:1529–1541.

Watkins SJ, Jonker L, Arthur HM . A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy. Cardiovasc Res 2006; 69:432–439.

Sorrentino A, Thakur N, Grimsby S, et al. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008; 10:1199–1207.

Yamashita M, Fatyol K, Jin C, et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 2008; 31:918–924.

Bradley JR, Pober JS . Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001; 20:6482–6491.

Haglund K, Dikic I . Ubiquitylation and cell signaling. EMBO J 2005; 24:3353–3359.

Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346–351.

Atfi A, Djelloul S, Chastre E, Davis R, Gespach C . Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 1997; 272:1429–1432.

Brown JD, DiChiara MR, Anderson KR, Gimbrone Jr MA, Topper JN . MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 1999; 274:8797–8805.

Zhang L, Wang W, Hayashi Y, et al. A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J 2003; 22:4443–4454.

Kim KY, Kim BC, Xu Z, Kim SJ . Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells. J Biol Chem 2004; 279:29478–29484.

Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T . BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 2000; 275:17647–17652.

Edlund S, Bu S, Schuster N, et al. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 2003; 14:529–544.

Liao JH, Chen JS, Chai MQ, Zhao S, Song JG . The involvement of p38 MAPK in transforming growth factor beta1-induced apoptosis in murine hepatocytes. Cell Res 2001; 11:89–94.

Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL . p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002; 115:3193–3206.

Jaffe AB, Hall A . Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21:247–269.

Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27–36.

Edlund S, Landstrom M, Heldin CH, Aspenstrom P . Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002; 13:902–914.

Shen X, Li J, Hu PP, et al. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem 2001; 276:15362–15368.

Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005; 307:1603–1609.

Gao L, Joberty G, Macara IG . Assembly of epithelial tight junctions is negatively regulated by Par6. Curr Biol 2002; 12:221–225.

Wang HR, Zhang Y, Ozdamar B, et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003; 302:1775–1779.

Wilkes MC, Murphy SJ, Garamszegi N, Leof EB . Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 2003; 23:8878–8889.

Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005; 307:1621–1625.

Foletta VC, Lim MA, Soosairajah J, et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 2003; 162:1089–1098.

Lee-Hoeflich ST, Causing CG, Podkowa M, et al. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J 2004; 23:4792–4801.

Edlund S, Landstrom M, Heldin CH, Aspenstrom P . Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42. J Cell Sci 2004; 117:1835–1847.

Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL . Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803–36810.

Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL . Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell 2001; 12:3328–3339.

Vinals F, Pouyssegur J . Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 2001; 21:7218–7230.

Wilkes MC, Mitchell H, Penheiter SG, et al. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 2005; 65:10431–10440.

Lamouille S, Derynck R . Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178:437–451.

Yi JY, Shin I, Arteaga CL . Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005; 280:10870–10876.

Valderrama-Carvajal H, Cocolakis E, Lacerte A, et al. Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 2002; 4:963–969.

Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL . SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998; 95:779–791.

Hayes S, Chawla A, Corvera S . TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 2002; 158:1239–1249.

Daniels CE, Wilkes MC, Edens M, et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004; 114:1308–1316.

Wang S, Wilkes MC, Leof EB, Hirschberg R . Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005; 19:1–11.

Chen RH, Su YH, Chuang RL, Chang TY . Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 1998; 17:1959–1968.

Song K, Wang H, Krebs TL, Danielpour D . Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 2006; 25:58–69.

Conery AR, Cao Y, Thompson EA, et al. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol 2004; 6:366–372.

Remy I, Montmarquette A, Michnick SW . PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 2004; 6:358–365.

Seoane J, Le HV, Shen L, Anderson SA, Massagué J . Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004; 117:211–223.

Gomis RR, Alarcon C, He W, et al. A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci USA 2006; 103:12747–12752.

Petritsch C, Beug H, Balmain A, Oft M . TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 2000; 14:3093–3101.

Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R . Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 1998; 18:6595–6604.

Janssens V, Goris J . Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001; 353:417–439.